Lark Health is a prominent player in the digital health space, offering innovative solutions for chronic disease management and prevention. With a mission to harness technology to enable individuals worldwide to lead healthier lives, Lark leverages AI digital health tech and connected devices to deliver personalized consumer experiences. Notably, the company has been a key player in the healthcare AI arena for over a decade and is recognized as the largest health plan provider for clinically proven obesity and pre-diabetes prevention programs.
The company's platform provides real-time, 24/7 personalized care coaching to over 2 million individuals through an intuitive, text message-like interface. Lark's scalable platform seamlessly integrates with existing healthcare and benefits infrastructure, enabling it to cater to diverse population needs within organizations and health plans. This approach has allowed Lark to offer a wide range of programs covering Weight Management Solutions, Prevention, Heart Health, Diabetes Prevention, Diabetes Management, and Hypertension Management, including a CDC-recognized Diabetes Prevention Program (DPP).
In October 2021, Lark successfully secured a $100.00M Series D investment with participation from a notable group of investors, including Franklin Templeton, King River Capital, Deerfield Management, Olive Tree Capital, PFM Health Sciences, IPD Capital, Weili Dai, and Castlepeak. With a strong industry presence and a proven track record, Lark Health continues to garner recognition, having been named one of CB Insights Digital Health 150, a finalist for the UCSF Digital Health Awards, and one of Fierce Healthcare's Fierce 15. This steady momentum and significant investment underscore Lark's potential for continued growth and impact within the Health Care industry. In conclusion, Lark Health's focus on leveraging technology, its established industry position, and the recent substantial investment point to a promising trajectory for the company as it continues to push boundaries in digital health solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series D | $100.00M | 8 | Weili Dai, Deerfield +1 | 13 Oct 2021 |
Debt Financing | $15.00M | 2 | 09 Oct 2020 | |
Series C | $55.00M | 9 | Weili Dai, Jonathan Fielding | 08 Oct 2020 |
Series B | Unknown | 1 | 17 Jul 2018 | |
Series B | $21.60M | 5 | Weili Dai, Philippe Suchet +2 | 01 Feb 2017 |
No recent news or press coverage available for Lark Health.